Key Players

Biotechnology Innovation Organization (BIO), Food and Drug Administration (FDA), National Center for Biotechnology Information (NCBI), National Science Foundation (NSF), Pharmaceutical Research & Manufacturers of America (PhRMA), Bio Century, Thermo Fisher Scientific Inc, Lonza, Corning Incorporated Kuraray Co Ltd, Becton, Dickinson and Company, Merck KGaA

Rising demand for organ transplantation might raise the 3D Cell Culture Market with 16% CAGR between 2022 and 2030

Medical science has achieved remarkable breakthroughs over the years and is still achieving. The technology of tissue regeneration has enabled the growth and repair of cells in the human body. The technique known as 3D cell culture helps biological cells to grow or interact with their surroundings in all three dimensions. Due to 3D cell culture providing more accurate data and more physiologically relevant information in vivo tests, it has become acceptable in comparison to 2D Cell culture.

Some factors that drive the growth of the global 3D cell culture market include organ and tissue regeneration capability and providing drug toxicology screening. Other factors contributing to the rapid growth of this market include rising approval from government bodies, growing awareness, increasing the incidence of cancer and rising demand for organs transplantation and lastly the varying applications of 3D cell culture market in biotech and pharmaceutical industry and rising prevalence of cancer worldwide. Demand for organ transplant has risen due to increasing prevalence of organ failures.

Market Research Future (MRFR) has published a research report about the global 3D cell culture market that anticipates the growth of this market between 2022 and 2030, with 25% CAGR (Compound Annual Growth Rate). The key findings of this report mention that by the end of forecast period, by product segmentation, consumables will be the highest growing segment of the global 3D cell culture market, with a CAGR of 16%. At the same time, among application, drug discovery will emerge as the largest segment with 25.75%. As a whole segment, The Pharmaceutical & Biotechnology Companies is expected to witness maximum growth with the CAGR of 26.13%.

The global 3D cell culture market has been segmented into the application, end user, product, technique, and lastly region. Based on application, this market has been segmented into cancer research, drug discovery, regenerative medicine, stem cell research, tissue screening & engineering, and others. Drug discovery is the process that helps the researchers to discover new candidate medications. Regenerative medicine is defined as a branch of translational research in molecular biology and tissue engineering. It deals with the process to replace, engineer or regenerate human cells, tissues or organs in order to restore or establish normal function. The process of borrowing cells from developed organs of the body and used for repairing unhealthy organs is called stem cell research. The purpose of tissue engineering is to assemble the functional constructs that heel, maintain and restore the damaged tissues or whole organs.

Segmentation: Magnetic 3d cell culture

The regional segmentation of the global 3D cell culture market covers The Americas (North America & South America), Europe, Asia Pacific, and the Middle East & Africa (MEA). With many key players based in the United States of America (USA) and due to the availability of advanced technology, North America is a bigger market than South America. In the USA, maximum organ transplant surgeries have taken place since 2016. In Europe, due to reasons same as North America, being more advanced technologically, Western Europe is a bigger market than Eastern Europe.

Competitive Analysis: Magnetic 3d Cell Culture 

In the Asia Pacific region, some countries like Japan and Singapore are technologically advanced. And in countries like India and China, the technological advancement is taking place at a slow but steady pace. This is primarily due to less expenditure (compared to governments in Western countries) from governments on medical healthcare. Other countries of Asia Pacific that are strong markets for 3D cell culture include Australia and South Korea, followed by rest of Asia Pacific countries. In the MEA countries, the market is small due to lack of technological advancement, less priority from the government to healthcare and lawless environment due to events like Arab Spring. Some countries in this region do have a decent amount of technological advancement and doctors with modern education because of which, they can be suitable markets for 3D cell culture. Such countries are Kuwait, Oman, Qatar, Saudi Arabia, and United Arab Emirates (UAE), followed by rest of MEA region.


Latest Industry News

  • ALPCO, a leading producer of research and clinical immunoassays, has announced its partnership with InSphero, AG. This partnership aims to provide customers with a complete solution to assess beta-cell function in islet micro tissue culture models. 24 JUL 2018
  • Collaborating with the University of Strathclyde, Biotechnology giant AMSBIO has set up a new joint venture company called ScreenIn3D, exploiting the latest advances in microfluidics and 3D cell culture, to develop a novel microfluidic screening platform. 6 JUL 2018

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 628 258 0071